Today's News

Kelowna, BC, May 16, 2016--(T-Net)--QHR Corporation (TSX-V: QHR), a leader in the Healthcare Information Technology sector, has announced financial results for its first quarter of 2016.

Q1 2016 revenue increased 15% year-over-year to a record $7.8 million, up from $6.8 million in Q1 2015. The Company also reported a 23% increase in recurring revenue run rate(1) to $27.4 million at the end of Q1 2016 compared to $22.3 million at the end of Q1 2015.

Other Selected Financial Information (continuing operations):

QHR continues to focus on the Electronic Medical Records (“EMR”) market in Canada, growing sales organically and pursuing complementary acquisitions and partnerships in an effort to expand its leadership position.

Mike Checkley, the Company's President and CEO observed that “this first quarter was another strong one, with good sales volume and improvement in operating efficiencies. We are getting better each quarter, strengthening our position as the leading EMR in Canada.”

Jerry Diener, Vice President and CFO of QHR Corporation, said "delivering an adjusted EBITDA margin of over 15% was an important milestone for us. In addition, this is the 5th consecutive quarter in which we have seen year-over-year growth in recurring revenue of 20% or more, while Days Sales Outstanding also improved significantly year-over-year to 23 days.”

Revenue

Record revenue of $7.83 million for Q1 2016, compared to $6.82 million for Q1 2015, was largely driven by continued organic growth of the Accuro™ EMR product.

Net Earnings (Loss)

Net earnings for continuing operations during Q1 2016 were $155,507, compared to a loss of $377,110 for Q1 2015.

Cash Flow

In Q1 2016, cash flow generated from operating activities was $2.3 million, compared to cash outflow for Q1 2015 of $2.2 million. The significant improvement seen in the quarter was driven primarily by reduction in accounts receivable.

At March 31, 2016, the Company had cash in the amount of $11.43 million and trade and other receivables of $1.95 million. The Company is not using any of its operating line and has no outstanding debt.

(1) Recurring revenue run rate, EBITDA and Adjusted EBIDTA are measures used by management in evaluating financial performance. Please refer to the cautionary statements under the heading “Non-IFRS Financial Measures”, below.

Full financial statements together with Management's Discussion and Analysis are available on SEDAR.

About QHR Corporation

QHR is a leader in Healthcare Technology, empowering providers and connecting patients. With a 12-year track record offering what is now the single leading Electronic Medical Records platform in Canada, QHR has a suite of complementary offerings that empower health professionals and drive the Company's growth. The Company's technologies and services enable secure medical records management for clinical environments, empowering health providers with tools for virtual care, including secure video and messaging, as well as tools for clinic management including scheduling, billing, and patient management. Health providers choose QHR to drive efficiencies within their practice and improve the quality of care delivered to patients.

Non-IFRS Financial Measures

(1)The numbers reflected here are from the unaudited condensed interim consolidated financial statements, for the period ended March 31, 2016, including comparatives, are expressed in Canadian dollars and have been prepared in accordance with International Accounting Standards (“IAS”) 34 “Interim Financial Reporting”. These financial statements do not include all of the information required in annual financial statements in accordance with International Financial Reporting Standards (“IFRS”). QHR also discloses and discusses certain non-IFRS financial measures, including Recurring Revenue Run-Rate, EBITDA and Adjusted EBITDA. QHR has presented these non-IFRS measures because Management believes they are relevant measures in evaluating QHR's performance.

EBITDA is defined as earnings before income tax expense, financing costs, depreciation, amortization and stock-based compensation. Adjusted EBITDA is defined as EBITDA adjusted with acquisition, transition and integration costs and other expenses that do not impact core operating performance.

Management believes that EBITDA and Adjusted EBITDA provide important measures of the Company's operating performance because they allow management, investors and others to evaluate and compare the Company's core operating results, including its return on capital and operating efficiencies, from period to period by removing the impact of its capital structure (interest expense), asset base (depreciation and amortization), tax consequences, other non-core operating items (acquisition costs) and other non-free cash items. Both EBITDA and Adjusted EBITDA do not have any standardized meaning prescribed by IFRS, other companies may calculate these non-IFRS measures differently, and therefore our EBITDA and Adjusted EBITDA may not be comparable to a similar titled measure by other companies. Accordingly, investors are cautioned not to place undue reliance on them and are also urged to read all accounting disclosures presented in the unaudited condensed interim consolidated financial statements and accompanying notes for the period ended March 31, 2016.

Legal Notice Regarding Forward Looking Statements

This news release may contain “forward looking statements” within the meaning of applicable Canadian securities legislation. These statements are subject to risks that may cause the actual results to be materially different in future periods from those expressed or implied by such forward looking statement. Forward-looking statements in this news release include those concerning the Company's belief that it is getting better every quarter, strengthening its position as the leading EMR provider in Canada, and that it can continue to expand its leadership position through organic sales growth and complementary acquisitions and partnerships. Risks that may prevent or delay the forward looking statements from coming to fruition include the possibility that the Company may not offer products that are acceptable to industry regulators or customers; competition, the availability of capital, changing regulatory requirements, the Company's ability to attract and retain key personnel, product obsolescence, work flow and market factors that could increase costs more than expected. QHR is a technology business development enterprise where investment and product enhancements must be carefully managed to achieve long-term revenue growth and profitability. It is the Company's policy not to update forward looking statements except to the extent required under applicable securities laws. Further information on the Company is available at www.sedar.com or at the Company's website, www.QHRtechnologies.com.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

QHR Technologies Inc. is a Canadian Healthcare Technology Company, bringing innovation to the healthcare system for Providers and their Patients. As a leader in the industry, QHR operates on the fundamental belief that technology will change the...